Mass spectrometry in gene therapy: Challenges and opportunities for AAV analysis

被引：8

作者：

Serrano, Mahalia A. C. ^{[1
]}

Furman, Ran ^{[1
]}

Chen, Guodong ^{[1
]}

Tao, Li ^{[1
]}

机构：

[1] Bristol Myers Squibb, Analyt Dev & Attribute Sci, Biol Dev Global Prod Dev & Supply, New Brunswick, NJ 10154 USA

来源：

DRUG DISCOVERY TODAY | 2023年 / 28卷 / 01期

关键词：

adeno-associated virus; gene therapy; mass spectrometry; native MS; charge detection MS; capsid viral protein; MOLECULAR-WEIGHT DETERMINATION; ADENOASSOCIATED VIRUS; VECTOR GENOME; CHO-CELLS; CHARGE; SEROTYPES; PARTICLE; QUANTIFICATION; EFFICIENT; PROTEINS;

D O I：

10.1016/j.drudis.2022.103442

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The characterization of adeno-associated virus (AAV)-based gene therapy products represents significant challenges owing to their extremely large molecular sizes, structural complexity and heterogeneity, and limited sample amounts. Mass spectrometry (MS) is one of the key analytical tools that can overcome these challenges and serve as an important technique for the analysis of multiple attributes. In this review, the current methodologies and emerging trends in MS analysis of AAV gene therapy products are presented, highlighting their advantages and unique capabilities in addressing key issues encountered in intact AAV vector analysis, capsid viral protein characterization and impurity analysis.

引用

页码：1 / 10

页数：10

共 50 条

[31] Addressing the top five challenges to AAV-based gene therapy with ddPCR
White, Mark
White, Mark, 2021, Mary Ann Liebert Inc. (41):
[32] AAV vectors advance cardiac gene therapy while overcoming challenges.
Muramatsu, Shin-ichi
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 400
[33] Mass spectrometry imaging in food safety and authenticity: Overcoming challenges and exploring opportunities
Tortorella, Sara
Bartels, Benjamin
Suman, Michele
Heeren, Ron M.A.
Righetti, Laura
Trends in Food Science and Technology, 2025, 155
[34] Ion mobility mass spectrometry in the omics era: Challenges and opportunities for metabolomics and lipidomics
Paglia, Giuseppe
Smith, Andrew J.
Astarita, Giuseppe
MASS SPECTROMETRY REVIEWS, 2022, 41 (05) : 722 - 765
[35] Characterizing Protein-Protein Interactions Using Mass Spectrometry: Challenges and Opportunities
Smits, Arne H.
Vermeulen, Michiel
TRENDS IN BIOTECHNOLOGY, 2016, 34 (10) : 825 - 834
[36] Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy
Duan, Dongsheng
HUMAN MOLECULAR GENETICS, 2006, 15 : R253 - R261
[37] An overview of the immune system, the challenges and opportunities it provides for gene therapy
Searle, P. F.
HUMAN GENE THERAPY, 2011, 22 (10) : A3 - A3
[38] Challenges in mass spectrometry
Stöcklin, R
Binz, PA
PROTEOMICS, 2002, 2 (07) : 825 - 827
[39] Immunology of AAV gene therapy
Wilson, James
HUMAN GENE THERAPY, 2007, 18 (10) : 943 - 943
[40] AAV Gene Therapy for Phenylketonuria
Ashley, Scott N.
Nordin, Jayme M. L.
Draper, Christine
Greig, Jenny A.
Wilson, James M.
MOLECULAR THERAPY, 2017, 25 (05) : 312 - 313

← 1 2 3 4 5 →